MDCO has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
MDCO has been removed from your Stock Email Alerts list.
| Company | Medicines (MDCO) | Takeda Pharmaceutical Co., Ltd. (TKPYY) | Teva Pharmaceutical Industries Ltd (TEVA) | Allergan, Inc. (AGN) | Forest Laboratories, Inc. (FRX) | (MRX) |
| Number of Guru Holders | 1 | 1 | 9 | 4 | 3 | 3 |
| Combined Weightings (%) | 0.44 | 1.32 | 10.79 | 4.11 | 14.91 | 0.63 |
| Number of Guru Buys:Sells (3 months) | 0 : 0 | 0 : 0 | 0 : 0 | 0 : 0 | 0 : 0 | 0 : 0 |
| Number of Guru Buys:Sells (6 months) | 0 : 0 | 0 : 0 | 0 : 0 | 0 : 0 | 0 : 0 | 0 : 0 |
| Number of Guru Buys:Sells (12 months) | 1 : 4 | 0 : 0 | 12 : 3 | 3 : 1 | 2 : 3 | 3 : 4 |
| Number of Insider Buys (3 months) | 0 | 0 | 0 | 0 | 0 | |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | |
| Price ($) | 35.76 | 24.23 | 40.23 | 101.41 | 38.53 | |
| Market Value ($mil) | 2,002 | 37,971 | 34,046 | 29,765 | 10,305 | |
| Revenue ($mil) | 587.73 | 15,466 | 20,116 | 5,918 | 3,126 | |
| P/E(ttm) | 61 | 38.20 | 20 | 35.20 | 89.30 | |
| P/S | 3.34 | 2.49 | 1.73 | 5.28 | 3.30 | |
| P/B | 3.33 | 1.38 | 1.51 | 5.18 | 0 | |
| Yield (%) | 0 | 4.58 | 2.36 | 0.20 | 0 | |
| Payout | 0 | 1.40 | 0.40 | 0.10 | 0 | |
| ROA (%) | 5.30 | 3.50 | 3.90 | 12 | 0 | |
| ROE (%) | 8.70 | 4.40 | 8.60 | 18.80 | 0 | |
| Operating Margin (%) | 14.90 | 17.60 | 10.90 | 27.80 | 4.10 | |
| Net Margin (%) | 9.20 | 8.20 | 9.70 | 18.90 | 3.40 | |
| Debt to Equity (%) | 0 | 15 | 46 | 28 | 0 | |
| 10-Year Rvn. Growth (%) | 20 | 6.20 | 17 | 12.20 | 8.60 | |
| 10-Year Earning Growth (%) | 0 | -3.50 | 16.40 | 0 | -3.80 | |
| 5-Year Rvn. Growth (%) | 10.10 | 2.80 | 14.60 | 7.50 | 1.40 | |
| 5-Year Earning Growth (%) | 0 | -17.10 | 27.70 | 0 | -26.40 | |
| 1-Year Rvn. Growth (%) | 17.50 | 7.10 | 6.60 | 7.50 | -30.20 | |
| 1-Year Earning Growth (%) | -71.40 | -46.90 | -37.50 | -11.10 | -103.40 |